These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28094666)

  • 1. Stage IV advanced diffuse large B-cell lymphoma in human immunodeficiency virus infection with achieving cure by using highly active antiretroviral therapy alone: a case report.
    Lim DH; Rhee JY; Park KW
    Int J STD AIDS; 2017 Aug; 28(9):932-936. PubMed ID: 28094666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term complete regression of nodal marginal zone lymphoma transformed into diffuse large B-cell lymphoma with highly active antiretroviral therapy alone in human immunodeficiency virus infection.
    Baraboutis IG; Marinos L; Lekakis LJ; Papastamopoulos V; Georgiou O; Tsagalou EP; Rondogianni P; Apostolidis J; Papadaki T; Skoutelis AT
    Am J Med Sci; 2009 Dec; 338(6):517-21. PubMed ID: 20010159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein Barré virus-negative diffuse large B-cell lymphoma in an HIV-infected man with a durable complete remission on highly active antiretroviral therapy alone.
    Koszyk-Szewczyk A; Bayerl M; Zurlo J; Drabick JJ
    South Med J; 2010 Jan; 103(1):76-80. PubMed ID: 19996843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma: results of a phase II trial.
    Ribera JM; Oriol A; Morgades M; González-Barca E; Miralles P; López-Guillermo A; Gardella S; López A; Abella E; García M;
    Br J Haematol; 2008 Feb; 140(4):411-9. PubMed ID: 18162120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of a plasmablastic lymphoma in a patient with HIV on highly active antiretroviral therapy.
    Nasta SD; Carrum GM; Shahab I; Hanania NA; Udden MM
    Leuk Lymphoma; 2002 Feb; 43(2):423-6. PubMed ID: 11999580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognosis of HIV-infected patients with diffuse large B-cell lymphoma treated with chemotherapy and highly active antiretroviral therapy is similar to that of HIV-negative patients receiving chemotherapy.
    Navarro JT; Lloveras N; Ribera JM; Oriol A; Mate JL; Feliu E
    Haematologica; 2005 May; 90(5):704-6. PubMed ID: 15921395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of aggressive HIV-associated non-Hodgkin's lymphoma with combination chemotherapy, biotherapy with rituximab and HAART: presentation of a therapeutic option.
    Klepfish A; Schattner A; Shvidel L; Shtalrid M; Haran M; Bentwich Z; Berrebi A
    Leuk Lymphoma; 2003 Feb; 44(2):349-51. PubMed ID: 12688356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy.
    Lim ST; Karim R; Tulpule A; Nathwani BN; Levine AM
    J Clin Oncol; 2005 Nov; 23(33):8477-82. PubMed ID: 16230675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Head and neck diffuse large B cell lymphomas (HN-DLBCL) in human immunodeficiency virus (HIV) positive patients: long-term results in the highly active antiretroviral therapy (HAART) era.
    De Felice F; Di Mino A; Grapulin L; Mistrulli ML; Musio D; Tombolini V
    Eur Arch Otorhinolaryngol; 2017 Oct; 274(10):3735-3739. PubMed ID: 28702826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spontaneous Regression of Refractory Diffuse Large B-Cell Lymphoma with Improvement in Immune Status with ART in a Patient with HIV: A Case Report and Literature Review.
    Birendra KC; Afzal MZ; Wentland KA; Hashmi H; Singh S; Ivan E; Lakhani N
    Am J Case Rep; 2015 Jun; 16():347-52. PubMed ID: 26046822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved outcome of AIDS-related lymphoma in patients with virologic response to highly active antiretroviral therapy.
    Navarro JT; Ribera JM; Oriol A; Tural C; Millá F; Feliu E
    J Acquir Immune Defic Syndr; 2003 Mar; 32(3):347-8. PubMed ID: 12626898
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety and efficacy of CHOP for treatment of diffuse large B-cell lymphoma with different combination antiretroviral therapy regimens: SCULPT study.
    Wong AY; Marcotte S; Laroche M; Sheehan NL; Kukreti V; Routy JP; Lemieux B; Seki JT; Rouleau D; Tseng A
    Antivir Ther; 2013; 18(5):699-707. PubMed ID: 23640963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disseminated plasmablastic lymphoma.
    Sharma R; Abdou S; Plymyer MR; Rohatgi C
    J Am Coll Surg; 2004 Oct; 199(4):654-5. PubMed ID: 15454154
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular characteristics of diffuse large B-cell lymphoma in human immunodeficiency virus-infected and -uninfected patients in the pre-highly active antiretroviral therapy and pre-rituximab era.
    Morton LM; Kim CJ; Weiss LM; Bhatia K; Cockburn M; Hawes D; Wang SS; Chang C; Altekruse SF; Engels EA; Cozen W
    Leuk Lymphoma; 2014 Mar; 55(3):551-7. PubMed ID: 23772639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
    Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM
    J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decrease in Epstein-Barr virus-positive AIDS-related lymphoma in the era of highly active antiretroviral therapy.
    Hishima T; Oyaizu N; Fujii T; Tachikawa N; Ajisawa A; Negishi M; Nakamura T; Iwamoto A; Hayashi Y; Matsubara D; Sasao Y; Kimura S; Kikuchi Y; Teruya K; Yasuoka A; Oka S; Saito K; Mori S; Funata N; Sata T; Katano H
    Microbes Infect; 2006 Apr; 8(5):1301-7. PubMed ID: 16697236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regression of large B-cell non-Hodgkin's lymphoma of stomach with HAART: case report and review.
    Khan F; Bauer F; Gazi G; Bilgrami S
    Leuk Lymphoma; 2006 Apr; 47(4):750-4. PubMed ID: 16886274
    [No Abstract]   [Full Text] [Related]  

  • 18. HIV-infection impact on clinical-biological features and outcome of diffuse large B-cell lymphoma treated with R-CHOP in the combination antiretroviral therapy era.
    Baptista MJ; Garcia O; Morgades M; Gonzalez-Barca E; Miralles P; Lopez-Guillermo A; Abella E; Moreno M; Sancho JM; Feliu E; Ribera JM; Navarro JT
    AIDS; 2015 Apr; 29(7):811-8. PubMed ID: 25730510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AIDS and non-Hodgkin's lymphoma. Experience at an oncological center in Mexico.
    Cornejo-Juárez P; Volkow-Fernández P; Avilés-Salas A; Calderón-Flores E
    Rev Invest Clin; 2008; 60(5):375-81. PubMed ID: 19227434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The microenvironment of AIDS-related diffuse large B-cell lymphoma provides insight into the pathophysiology and indicates possible therapeutic strategies.
    Liapis K; Clear A; Owen A; Coutinho R; Greaves P; Lee AM; Montoto S; Calaminici M; Gribben JG
    Blood; 2013 Jul; 122(3):424-33. PubMed ID: 23652804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.